This 10th edition conference on Strategic Alliance Management for Pharma will focus on demonstrating the value and role of alliance management, strengthening the skills of alliance function, aligning the right resources and projects, integrating into global portfolio strategy.

“EUROPE’S MOST EXCITING DRUG SAFETY & PV EVENT!

The World Drug Safety Congress Europe is empowering patients, physicians, pharma, biotech and consumers to make the best drug safety decisions.

Event will bring together 180+ speakers and 600+ key thought leaders to explore these challenges within pharmacovigilance. These key players from biopharma sector will attend in 2020:

– DRUG SAFETY

– PHARMACOVIGILANCE

– DATA ANALYTICS

– EPIDEMIOLOGY

Explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches; discuss how you can tackle the challenges of social media and drug safety legislation globally.

The meeting will bridge the gap between international regulatory bodies, industry professionals & patient representatives.

Who will attend?

Chief Safety Officers
Chief Medical Officers
VP’s Safety
Regulatory Officers
Heads of Clinical Safety
Heads of Patient Groups
Epidemiology Managers
Heads of Toxicology
Heads of R+D
Heads of Labelling
Heads of Safety Surveillance
Post authorisation afety Managers
Heads of Drug Safety/ PV

QPPVs”

For details and to register, visit the website at http://www.terrapinn.com/DSEU/Farmavitar